Castleark Management LLC Global Blood Therapeutics, Inc. Transaction History

Castleark Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $2.37 Million - $3.34 Million	-44,835 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $1.86 Million - $3.13 Million	-38,270 Reduced 46.05%	44,835 $2.83 Million
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $2.32 Million - $4.86 Million	55,725 Added 203.52%	83,105 $4.25 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $1.25 Million - $2.24 Million	27,380 New	27,380 $2.18 Million
Q2 2019 Aug 13, 2019	SELL	$52.6 - $63.29 $4.71 Million - $5.67 Million	-89,545 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $58,785 - $78,615	-1,470 Reduced 1.62%	89,545 $4.74 Million
Q4 2018 Feb 12, 2019	BUY	$31.54 - $46.67 $2.87 Million - $4.25 Million	91,015 New	91,015 $3.74 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.